Search for: "Downing v. Abbott Laboratories"
Results 21 - 40
of 98
Sorted by Relevance
|
Sort by Date
4 Nov 2010, 10:59 am
Astrazeneca v. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) Products… [read post]
29 Jun 2010, 10:43 am
Abbott True to our standard annual mid-year update format, we are providing you with condensed summaries of each of the CEQA cases issued this year. [read post]
3 May 2007, 9:34 am
" On April 30, it editorialized again: "Earlier this month, Thailand browbeat Abbott Laboratories into reducing the price of an HIV/AIDS drug, Kaletra, by threatening to seize its patent. [read post]
11 Nov 2010, 5:31 am
TiVo, Inc. v. [read post]
11 Nov 2010, 5:31 am
TiVo, Inc. v. [read post]
23 Jul 2013, 12:00 am
Novozymes v. [read post]
15 Sep 2015, 6:17 pm
Abbott Laboratories, Inc., No. 1:13-cv-144, slip op. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
29 Jun 2010, 6:01 pm
USA (Patent Docs) Lexapro (Escitalopram) – US: Infosint’s infringement verdict over Lexapro overturned, patent ruled invalid (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
30 Jun 2010, 5:52 am
USA (Patent Docs) Lexapro (Escitalopram) – US: Infosint’s infringement verdict over Lexapro overturned, patent ruled invalid (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
5 Jun 2015, 6:40 am
Abbott Laboratories, 740 F.3d 471 (9th Cir. 2014). [read post]
25 Jan 2014, 4:44 pm
Abbott Laboratories, a civil antitrust dispute between two pharmaceutical companies. [read post]
20 Feb 2007, 7:03 am
Abbott Laboratories (06-577). ** Whether the Constitution restricts a state's authority to limit voters' rights to put a specific issue on a ballot measure. [read post]
14 Jun 2007, 6:55 am
Abbott Laboratories, 745 A.2d 1174 (N.J. 2000). [read post]
1 Oct 2010, 5:25 am
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
11 Nov 2022, 9:40 am
Abbott Laboratories, 636 F.3d 1341(Fed. [read post]
21 Mar 2013, 7:55 pm
AIA Cited by CAFC as Remedying Known Patent Reexamination Deficiency As predicted based upon the earlier oral argument, the Federal Circuit closed the door on the potential for discovery in inter partes patent reexamination in Abbott Laboratories v. [read post]
15 Jul 2010, 2:39 pm
Abbott Laboratories, 607 P.2d 924 (Cal. 1980), a DES case. [read post]
6 Jul 2007, 4:29 am
Anybody can go down to the hardware store and buy a lawnmower for any reason (or no reason) at all. [read post]
